← REGULATORY CHANGES
FEDERAL REGISTER · RULESeptember 16, 2024IN FORCE

Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVESep 16, 2024
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGDevice
Document type
Rule
Agency
Health and Human Services Department
Published
September 16, 2024
Effective
September 16, 2024
Document number
2024-20999
CFR references
21 CFR 876
Docket
FDA-2024-N-4082
ABSTRACT

The Food and Drug Administration (FDA, Agency, or we) is classifying the pediatric continuous renal replacement therapy system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the pediatric continuous renal replacement therapy system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices.

Abstract as published in the Federal Register.